(S)-11-Formy-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
![(S)-11-Formy-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione结构式](https://image.chemsrc.com/caspic/413/80758-83-4.png)
(S)-11-Formy-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione结构式
|
常用名 | (S)-11-Formy-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione | 英文名 | (S)-11-Formy-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione |
|---|---|---|---|---|
| CAS号 | 80758-83-4 | 分子量 | 376.36200 | |
| 密度 | 1.54g/cm3 | 沸点 | 817ºC at 760 mmHg | |
| 分子式 | C21H16N2O5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 447.9ºC |
| 英文名 | camptothecin-7-aldehyde |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.54g/cm3 |
|---|---|
| 沸点 | 817ºC at 760 mmHg |
| 分子式 | C21H16N2O5 |
| 分子量 | 376.36200 |
| 闪点 | 447.9ºC |
| 精确质量 | 376.10600 |
| PSA | 98.49000 |
| LogP | 1.89210 |
| 折射率 | 1.744 |
|
~%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. Patent: WO2009/16068 A1, 2009 ; Location in patent: Page/Page column 8 ; |
|
~68%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Miyasaka, Tadashi; Sawada, Seigo; Nokata, Ken-ichiro Heterocycles, 1981 , vol. 16, # 10 p. 1719 - 1721 |
|
~19%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Sawada; Nokata; Furuta; Yokokura; Miyasaka Chemical and Pharmaceutical Bulletin, 1991 , vol. 39, # 10 p. 2574 - 2580 |
|
~90%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Sawada; Nokata; Furuta; Yokokura; Miyasaka Chemical and Pharmaceutical Bulletin, 1991 , vol. 39, # 10 p. 2574 - 2580 |
|
~%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Sawada; Nokata; Furuta; Yokokura; Miyasaka Chemical and Pharmaceutical Bulletin, 1991 , vol. 39, # 10 p. 2574 - 2580 |
|
~67%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Sawada; Nokata; Furuta; Yokokura; Miyasaka Chemical and Pharmaceutical Bulletin, 1991 , vol. 39, # 10 p. 2574 - 2580 |
|
~68%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Sawada; Nokata; Furuta; Yokokura; Miyasaka Chemical and Pharmaceutical Bulletin, 1991 , vol. 39, # 10 p. 2574 - 2580 |
|
~%
(S)-11-Formy-4-... 80758-83-4 |
| 文献：Ricci, Antonio; Marinello, Jessica; Bortolus, Marco; Sanchez, Albert; Grandas, Anna; Pedroso, Enrique; Pommier, Yves; Capranico, Giovanni; Maniero, Anna Lisa; Zagotto, Giuseppe Journal of Medicinal Chemistry, 2011 , vol. 54, # 4 p. 1003 - 1009 |
![(S)-(4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl)methyl 2-phenylacetate结构式](https://image.chemsrc.com/caspic/206/78287-22-6.png)
![(S)-11-DimethoxyMethyl-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione结构式](https://image.chemsrc.com/caspic/376/84017-99-2.png)
| camptothecin-7-carbaldehyde |
| 7-formyl CPT |
| coptothecin-7-carbaldehyde |
| (S)-11-Formy-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione |
| (20S)-camptothecin-7-carboxaldehyde |
| 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-carboxaldehyde,4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-,(S) |
| 7-formyl camptothecin |
| (S)-4-Ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-11-carboxaldehyde |
